These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4119813)

  • 21. Getting ready for certification: urinary tract inflammation and disease.
    Linn MM
    Urol Nurs; 2007 Aug; 27(4):324-5. PubMed ID: 17877104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Amdiĭ RE
    Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Editorial: benign prostatic hyperplasia.
    Schäfer W
    J Urol; 1996 Jan; 155(1):293. PubMed ID: 7490865
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis].
    Savin VF; Antonov NM; Arkannikov AB
    Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prostatic hypertrophy and its treatment].
    Potempa J
    Munch Med Wochenschr; 1966 Dec; 108(48):2446-50. PubMed ID: 4166192
    [No Abstract]   [Full Text] [Related]  

  • 26. Benign hyperplasia of the prostate.
    Crassweller PO
    Can Nurse; 1968 Dec; 64(12):32-4. PubMed ID: 4176919
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hugh Hampton Young, benign prostatic hyperplasia, and "the cure of prostatic obstruction".
    Parsons JK; Partin AW
    J Am Coll Surg; 2005 Nov; 201(5):654-5. PubMed ID: 16256905
    [No Abstract]   [Full Text] [Related]  

  • 30. [The value of self-assessment in management of patients with benign prostatic hyperplasia].
    Schneider HJ
    Fortschr Med; 1995 Jun; 113(16):250-2. PubMed ID: 7543430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transurethral prostatic thermotherapy with microwaves (prostatron system) in bladder obstruction secondary to benign prostatic hypertrophy].
    Mompó Sanchis JA; Paya Navarro JJ; Prosper Rovira F
    Arch Esp Urol; 1994 Jun; 47(5):461-71. PubMed ID: 7524453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Keqin z, et al. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement (Urology 2007;70:1096-1099).
    Chung SD; Chiu B; Yu HJ
    Urology; 2009 Jan; 73(1):216. PubMed ID: 19111744
    [No Abstract]   [Full Text] [Related]  

  • 34. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
    Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
    Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia].
    Wu Z; Wu K; Wang B
    Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of levorin on the chromatin of the prostate of dogs in its hypertrophy].
    Kravchenko LS; Oksman AIa; Konstantinova IM; Tereshin IM
    Antibiotiki; 1979 Mar; 24(3):212-7. PubMed ID: 87145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostakath in urinary outflow obstruction.
    Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
    Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.
    Suardi N; Scattoni V; Briganti A; Salonia A; Naspro R; Gallina A; Cestari A; Colombo R; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Jun; 53(6):1180-5. PubMed ID: 17659829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.